JSPR (Jasper Therapeutics Inc.) stock is in for a key growth catalyst

As of close of business last night, Jasper Therapeutics Inc.’s stock clocked out at $1.79, down -7.25% from its previous closing price of $1.93. In other words, the price has decreased by -$0.1400 from its previous closing price. On the day, 732736 shares were traded. JSPR stock price reached its highest trading level at $2.0400 during the session, while it also had its lowest trading level at $1.7600.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

To gain a deeper understanding of JSPR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.10 and its Current Ratio is at 7.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on February 28, 2022, initiated with a Overweight rating and assigned the stock a target price of $10.

On November 08, 2021, Credit Suisse started tracking the stock assigning a Outperform rating and target price of $15.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 27 when Lis William sold 24,743 shares for $2.08 per share. The transaction valued at 51,404 led to the insider holds 40,486 shares of the business.

Lis William sold 24,743 shares of JSPR for $50,030 on Jun 24. The Director now owns 65,229 shares after completing the transaction at $2.02 per share.

Stock Price History:

Over the past 52 weeks, JSPR has reached a high of $5.81, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is 0.9228, while the 200-Day Moving Average is calculated to be 1.7643.

Shares Statistics:

It appears that JSPR traded 2.91M shares on average per day over the past three months and 9.38M shares per day over the past ten days. A total of 36.57M shares are outstanding, with a floating share count of 25.74M. Insiders hold about 5.90% of the company’s shares, while institutions hold 61.50% stake in the company. Shares short for JSPR as of Oct 13, 2022 were 44.76k with a Short Ratio of 0.26M, compared to 7.72k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.12% and a Short% of Float of 0.23%.

Earnings Estimates

As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.35 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.37, while EPS last year was -$0.69. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.31 and low estimates of -$0.41.

Analysts are recommending an EPS of between -$1.01 and -$1.34 for the fiscal current year, implying an average EPS of -$1.13. EPS for the following year is -$1.24, with 4 analysts recommending between -$0.67 and -$1.62.